Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Gross Margin (2016 - 2025)

Bio-Techne has reported Gross Margin over the past 17 years, most recently at 64.65% for Q4 2025.

  • Quarterly results put Gross Margin at 64.65% for Q4 2025, down 63.0% from a year ago — trailing twelve months through Dec 2025 was 65.22% (down 41.0% YoY), and the annual figure for FY2025 was 64.8%, down 161.0%.
  • Gross Margin for Q4 2025 was 64.65% at Bio-Techne, down from 65.65% in the prior quarter.
  • Over the last five years, Gross Margin for TECH hit a ceiling of 8979.75% in Q3 2022 and a floor of 62.72% in Q2 2025.
  • Median Gross Margin over the past 5 years was 67.47% (2022), compared with a mean of 512.46%.
  • Biggest five-year swings in Gross Margin: soared 891340bps in 2022 and later plummeted -891288bps in 2023.
  • Bio-Techne's Gross Margin stood at 68.22% in 2021, then fell by -1bps to 67.52% in 2022, then dropped by -4bps to 64.78% in 2023, then increased by 1bps to 65.27% in 2024, then dropped by -1bps to 64.65% in 2025.
  • The last three reported values for Gross Margin were 64.65% (Q4 2025), 65.65% (Q3 2025), and 62.72% (Q2 2025) per Business Quant data.